{"contentid": 488406, "importid": NaN, "name": "Add blood clot risk to J&J jab product info, says EMA", "introduction": "At its meeting on Tuesday, the European Medicines Agency\u00e2\u0080\u0099s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) decided that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen.", "content": "<p>At its meeting on Tuesday, the European Medicines Agency&rsquo;s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) decided that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen.</p>\n<p>The PRAC also concluded that these events should be listed as very rare side effects of the vaccine.</p>\n<p><span class=\"pullQuote\">\"The overall benefits of COVID-19 Vaccine Janssen in preventing COVID-19 outweigh the risks of side effects\"</span>The committee took into account what it said was all currently available evidence including eight reports from the USA of serious cases of unusual blood clots associated with low levels of blood platelets, one of which had a fatal outcome, out of more than seven million Americans that have so far received Janssen&rsquo;s vaccine.</p>\n<p>All cases occurred in people under 60 years of age within three weeks of being given the vaccination, the majority in women. Based on the currently available evidence, specific risk factors have not been confirmed.</p>\n<p>The PRAC noted that the blood clots occurred mostly at unusual sites such as in veins in the brain, abdomen and arteries, together with low levels of blood platelets and sometimes bleeding.</p>\n<p>The cases reviewed were very similar to the cases that occurred with the COVID-19 vaccine developed by AstraZeneca (LSE: AZN), Vaxzevria, according to the committee.</p>\n<p>An EMA statement added: &ldquo;COVID-19 is associated with a risk of hospitalization and death. The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of COVID-19 Vaccine Janssen in preventing COVID-19 outweigh the risks of side effects.</p>\n<p>&ldquo;As for all vaccines, EMA will continue to monitor the vaccine&rsquo;s safety and effectiveness and provide the public with the latest information.&rdquo;</p>\n<p>Image: Rob Acket</p>", "date": "2021-04-20 16:33:00", "meta_title": NaN, "meta_keywords": "blood, COVID-, vaccine, risk, product, platelets, clots, Janssen, PRAC, unusual, committee, added, information, cases, clot, effects, side, info, Medicines", "meta_description": "At its meeting on Tuesday, the European Medicines Agency\u00e2\u0080\u0099s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) decided that a warning about unusual blood c", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-20 16:05:43", "updated": "2021-04-20 17:07:31", "access": NaN, "url": "https://www.thepharmaletter.com/article/add-blood-clot-risk-to-j-j-jab-product-info-says-ema", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "ema_building-credit_rob_acket.jpg", "image2id": "ema_building-credit_rob_acket_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Focus On, Regulation", "geography_tag": "Europe, USA", "company_tag": "Janssen, Johnson & Johnson", "drug_tag": "COVID-19 Vaccine Janssen", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-20 16:33:00"}